Gene · 23576
Papers1,467
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,467
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cardiovascular Compatibility of Proton Pump Inhibitors: Practice Recommendations. | Cardiol Ther | 2023 | 37947939 | PubTator, text mining | PubMed |
| Automated exploitation of deep learning for cancer patient stratification across multiple types. | Bioinformatics | 2023 | 37934154 | PubTator, text mining | PubMed |
| The potential mechanism of gut microbiota-microbial metabolites-mitochondrial axis in progression of diabetic kidney disease. | Mol Med | 2023 | 37907885 | PubTator, text mining | PubMed |
| Are Proton Pump Inhibitors Contributing in Emerging New Hypertensive Population? | Pharmaceuticals (Basel) | 2023 | 37895858 | PubTator, text mining | PubMed |
| Roles of Oxidative Injury and Nitric Oxide System Derangements in Kawasaki Disease Pathogenesis: A Systematic Review. | Int J Mol Sci | 2023 | 37895129 | PubTator, text mining | PubMed |
| HTATIP2 regulates arteriogenic activity in monocytes from patients with limb ischemia. | JCI Insight | 2023 | 37847559 | PubTator, text mining | PubMed |
| Nitric Oxide as a Determinant of Human Longevity and Health Span. | Int J Mol Sci | 2023 | 37833980 | PubTator, text mining | PubMed |
| Tissue fibrosis induced by radiotherapy: current understanding of the molecular mechanisms, diagnosis and therapeutic advances. | J Transl Med | 2023 | 37814303 | PubTator, text mining | PubMed |
| The Association Between Fluid Overload and Endothelial Dysfunction in Chronic Kidney Failure Patients Undergoing Hemodialysis Twice a Week. | Cureus | 2023 | 37779742 | PubTator, text mining | PubMed |
| Impaired Nitric Oxide Synthetase Activity in Primary Ciliary Dyskinesia-Data-Driven Hypothesis. | J Clin Med | 2023 | 37762950 | PubTator, text mining | PubMed |
| The Role of miRNA in Renal Fibrosis Leading to Chronic Kidney Disease. | Biomedicines | 2023 | 37760798 | PubTator, text mining | PubMed |
| Diurnal Variation of L-Arginine and the Cardiovascular Risk Markers Asymmetric and Symmetric Dimethylarginine and Homoarginine in Rotating Night Shift Workers and Controls. | Biomolecules | 2023 | 37759682 | PubTator, text mining | PubMed |
| The use of intravenous immunoglobulin in the treatment of Hashimoto's encephalopathy: case based review. | Front Neurol | 2023 | 37745658 | PubTator, text mining | PubMed |
| Multi-Omics Analysis of NCI-60 Cell Line Data Reveals Novel Metabolic Processes Linked with Resistance to Alkylating Anti-Cancer Agents. | Int J Mol Sci | 2023 | 37686047 | PubTator, text mining | PubMed |
| Altered expression of the L-arginine/nitric oxide pathway in ovarian cancer: metabolic biomarkers and biological implications. | BMC Cancer | 2023 | 37684587 | PubTator, text mining | PubMed |
| Arginine, Transsulfuration, and Folic Acid Pathway Metabolomics in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. | Cells | 2023 | 37681911 | PubTator, text mining | PubMed |
| Sertoli cell-enriched proteins in mouse and human testicular interstitial fluid. | PLoS One | 2023 | 37656709 | PubTator, text mining | PubMed |
| Hepatic DDAH1 mitigates hepatic steatosis and insulin resistance in obese mice: Involvement of reduced S100A11 expression. | Acta Pharm Sin B | 2023 | 37655336 | PubTator, text mining | PubMed |
| GC-MS and GC-MS/MS measurement of malondialdehyde (MDA) in clinical studies: Pre-analytical and clinical considerations. | J Mass Spectrom Adv Clin Lab | 2023 | 37637438 | PubTator, text mining | PubMed |
| Plasma proteomic profiling discovers molecular features associated with upper tract urothelial carcinoma. | Cell Rep Med | 2023 | 37633276 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23576/papers?page=5